[go: up one dir, main page]

MA26626A1 - Derives de 2"-desoxy-hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives de 2"-desoxy-hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
MA26626A1
MA26626A1 MA25566A MA25566A MA26626A1 MA 26626 A1 MA26626 A1 MA 26626A1 MA 25566 A MA25566 A MA 25566A MA 25566 A MA25566 A MA 25566A MA 26626 A1 MA26626 A1 MA 26626A1
Authority
MA
Morocco
Prior art keywords
preparation
compositions containing
deoxy
novel
pharmaceutical compositions
Prior art date
Application number
MA25566A
Other languages
English (en)
Inventor
Gerald Linde Ii Robert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26626A1 publication Critical patent/MA26626A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSÉS DE FORMULE, DANS LAQUELLE R1 ET R2 REPRÉSENTENT DIVERS RADICAUX. ELLE CONCERNE ÉGALEMENT UN PROCÉDÉ POUR LEUR PRÉPARATION ET DES COMPOSITIONS PHARMuACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSÉS ET COMPOSITIONS POUR LE TERAITEMENT D'INFECTIONS BACTRIENNES ET D'INFECTIONS PAR DES PROTOZOAIRES.
MA25566A 1998-05-04 1999-05-03 Derives de 2"-desoxy-hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant MA26626A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8405898P 1998-05-04 1998-05-04

Publications (1)

Publication Number Publication Date
MA26626A1 true MA26626A1 (fr) 2004-12-20

Family

ID=22182624

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25566A MA26626A1 (fr) 1998-05-04 1999-05-03 Derives de 2"-desoxy-hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (38)

Country Link
US (1) US6342497B1 (fr)
EP (1) EP1077984B1 (fr)
JP (1) JP2002513798A (fr)
KR (1) KR100396099B1 (fr)
CN (1) CN1299367A (fr)
AP (1) AP1069A (fr)
AR (1) AR015776A1 (fr)
AT (1) ATE243218T1 (fr)
AU (1) AU762302B2 (fr)
BG (1) BG104995A (fr)
BR (1) BR9910232A (fr)
CA (1) CA2331261C (fr)
DE (1) DE69908936T2 (fr)
DK (1) DK1077984T3 (fr)
DZ (1) DZ2779A1 (fr)
EA (1) EA004374B1 (fr)
ES (1) ES2199559T3 (fr)
GT (1) GT199900058A (fr)
HN (1) HN1999000064A (fr)
HR (1) HRP20000748A2 (fr)
HU (1) HUP0102412A3 (fr)
ID (1) ID26368A (fr)
IL (1) IL139020A0 (fr)
IS (1) IS5680A (fr)
MA (1) MA26626A1 (fr)
NO (1) NO20005551L (fr)
NZ (1) NZ507450A (fr)
OA (1) OA11507A (fr)
PA (1) PA8471901A1 (fr)
PE (1) PE20000440A1 (fr)
PL (1) PL344085A1 (fr)
PT (1) PT1077984E (fr)
SK (1) SK16442000A3 (fr)
TN (1) TNSN99084A1 (fr)
TR (1) TR200003249T2 (fr)
WO (1) WO1999057127A1 (fr)
YU (1) YU64300A (fr)
ZA (1) ZA993063B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002154A0 (en) 1998-12-02 2001-05-09 Pfizer Prod Inc Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
IL152984A0 (en) 2000-06-02 2003-06-24 Pfizer Prod Inc Hygromycin a derivatives for the treatment of bacterial and protozoal infections
CN102168034B (zh) * 2010-11-29 2012-12-05 中国科学院南海海洋研究所 一种海洋链霉菌以及利用该菌制备替达霉素a和b的方法
WO2020041179A1 (fr) * 2018-08-20 2020-02-27 Northeastern University Composés d'hygromycine a et procédés de traitement de maladies à spirochètes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2832356B2 (ja) * 1988-03-31 1998-12-09 武田薬品工業株式会社 ハイグロマイシン類の合成中間体および製造法

Also Published As

Publication number Publication date
EP1077984A1 (fr) 2001-02-28
ZA993063B (en) 2000-11-03
OA11507A (en) 2004-05-13
CA2331261A1 (fr) 1999-11-11
PA8471901A1 (es) 2000-09-29
AP1069A (en) 2002-05-14
TNSN99084A1 (fr) 2005-11-10
IS5680A (is) 2000-10-24
HUP0102412A3 (en) 2003-07-28
KR20010043267A (ko) 2001-05-25
ES2199559T3 (es) 2004-02-16
TR200003249T2 (tr) 2001-03-21
HN1999000064A (es) 2000-01-12
KR100396099B1 (ko) 2003-08-27
ATE243218T1 (de) 2003-07-15
JP2002513798A (ja) 2002-05-14
SK16442000A3 (sk) 2001-07-10
YU64300A (sh) 2003-07-07
DE69908936T2 (de) 2004-05-19
AU762302B2 (en) 2003-06-19
DE69908936D1 (en) 2003-07-24
PL344085A1 (en) 2001-09-24
PE20000440A1 (es) 2000-05-26
WO1999057127A1 (fr) 1999-11-11
NO20005551D0 (no) 2000-11-03
NZ507450A (en) 2003-08-29
IL139020A0 (en) 2001-11-25
DK1077984T3 (da) 2003-09-15
AP9901525A0 (en) 1999-06-30
DZ2779A1 (fr) 2005-04-23
US6342497B1 (en) 2002-01-29
BG104995A (bg) 2001-07-31
AU2850899A (en) 1999-11-23
HRP20000748A2 (en) 2001-06-30
EA004374B1 (ru) 2004-04-29
EP1077984B1 (fr) 2003-06-18
BR9910232A (pt) 2001-01-09
NO20005551L (no) 2001-01-02
GT199900058A (es) 2000-10-07
ID26368A (id) 2000-12-14
CN1299367A (zh) 2001-06-13
HUP0102412A2 (hu) 2001-11-28
PT1077984E (pt) 2003-09-30
CA2331261C (fr) 2004-07-27
EA200001028A1 (ru) 2001-04-23
AR015776A1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
MA24729A1 (fr) Macrolides nouveaux.
MA26723A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26733A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26717A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26718A1 (fr) Derives de quinoleine-2-one a substituant heteroaryle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA25035A1 (fr) Derives de 3-azabicyclo [3,1,0] hexane nouveaux, procede pour leur preparation et compositions les contenant
MA26697A1 (fr) Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99169A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26689A1 (fr) Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99142A1 (fr) Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
MA26727A1 (fr) Derives nouveaux de pyrimidine inhibiteurs de sorbitol deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant
TNSN99031A1 (fr) Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26696A1 (fr) Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99205A1 (fr) Macrolides antibiotiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN00235A1 (fr) Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant
MA27676A1 (fr) 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant